Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Disseminated intravascular coagulation (DIC) is a common occurrence during clinical sepsis and can be induced in the experimental host by LPS. Fibrin deposition in the hepatic microcirculation has been observed within 30 min of i.v. injection of LPS. Because mononuclear phagocytes have been shown to produce a
PCA
after exposure to LPS, we have examined the ability of a homogeneous population of explanted hepatic macrophages to express
PCA
. Addition of as little as 10 ng/ml of LPS stimulated a 15- to 20-fold increase in
PCA
over control culture levels within 7 1/2 hr post-treatment. The
PCA
was found to be membrane-associated, with approximately 90 to 95% of the total
PCA
present in the cellular lysates, and more than 85% was inhibited by pretreatment of the cells with the diazonium salt of sulfanilic acid, an inhibitor of ecto-enzymes. In contrast to tissue thromboplastin produced by other M phi populations, the H-M phi
PCA
was found to be markedly sensitive both to heat inactivation at 56 degrees C and to inhibition by 1 mM
DFP
. Additionally, assays involving both a 1-stage coagulation test as well as an enzyme assay with a Factor Xa-specific substrate (using normal and deficient human plasmas) demonstrated that the H-M phi
PCA
appears to activate Factor X directly. Unlike tissue thromboplastin, the H-M phi
PCA
is non-dependent of Factor VII activation. These studies: 1) demonstrate the LPS induces a unique
PCA
in the H-M phi, and 2) support a role for the H-M phi in the initiation of DIC in endotoxemic shock.
...
PMID:The induction of a unique procoagulant activity in rabbit hepatic macrophages by bacterial lipopolysaccharides. 702 10